None
Conditions
Interventions
Sponsors
Women’s Hospital, Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Treatment cycle time: patients who come to the hospital for complete treatment cycles of preimplantation aneuploidy testing (PGT-A), preimplantation single gene disease testing (PGT-M), or preimplantation chromosomal structural rearrangement testing (PGT-SR) between January 1, 2018 and December 31, 2024. 2. Embryonic genetic data: embryos with clear, available chromosomal testing results for PGT-A or PGT-M. 3. Data integrity: relatively complete records related to the core exposure factors of the study could be extracted from the electronic medical record.
Exclusion criteria
Exclusion criteria: Treatment cycles that met the inclusion criteria were excluded if any of the following occurred: 1. Ivf cycles using donor eggs or sperm. 2. Either of the couples had numerical chromosome abnormalities confirmed by karyotype analysis. 3. Cases with apparently contradictory or unreliable clinical information records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Embryonic aneuploidy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Independent effect values of key exposure factors; | — |
Countries
China
Contacts
Public ContactLv Pingping
Women’s Hospital, Zhejiang University School of Medicine
Outcome results
None listed